Randomized controlled clinical study evaluating the efficacy and safety of intratumoral treatment of canine mast cell tumors with tigilanol tiglate (EBC‐46)

OBJECTIVE: To evaluate the efficacy and safety of tigilanol tiglate (TT) for local intratumoral treatment of mast cell tumors (MCTs) in dogs. METHODS: A randomized controlled clinical study in 2 phases involving 123 dogs with cytologically diagnosed MCT. Phase 1 compared 81 TT‐treated dogs with 42 c...

Descripción completa

Detalles Bibliográficos
Autores principales: De Ridder, Thomas R., Campbell, Justine E., Burke‐Schwarz, Cheryl, Clegg, David, Elliot, Emily L., Geller, Samuel, Kozak, Wendy, Pittenger, Stephen T., Pruitt, Jennifer B., Riehl, Jocelyn, White, Julie, Wiest, Melissa L., Johannes, Chad M., Morton, John, Jones, Pamela D., Schmidt, Peter F., Gordon, Victoria, Reddell, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
SMALL ANIMAL
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848366/
https://www.ncbi.nlm.nih.gov/pubmed/32542733
http://dx.doi.org/10.1111/jvim.15806

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848366/
https://www.ncbi.nlm.nih.gov/pubmed/32542733
http://dx.doi.org/10.1111/jvim.15806

Ejemplares similares